XML 47 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023   498,000      
Beginning balance at Dec. 31, 2023 $ 13,227 $ 5 $ 15 $ 13,301 $ (94)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 546     546  
Other comprehensive income (loss)         (62)
Other comprehensive income (loss) (62)        
Common stock issued, stock-based compensation plans (in shares)   1,000      
Common stock issued, stock-based compensation plans 20   20    
Stock-based compensation expense 42   42    
Repurchases of common stock (in shares)   (2,000)      
Repurchases of common stock (133)   (57) (76)  
Dividends declared (150)     (150)  
Ending balance (in shares) at Mar. 31, 2024   497,000      
Ending balance at Mar. 31, 2024 13,490 $ 5 20 13,621 (156)
Beginning balance (in shares) at Dec. 31, 2023   498,000      
Beginning balance at Dec. 31, 2023 13,227 $ 5 15 13,301 (94)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,694        
Other comprehensive income (loss) 136       136
Ending balance (in shares) at Sep. 30, 2024   496,000      
Ending balance at Sep. 30, 2024 14,452 $ 5 58 14,347 42
Beginning balance (in shares) at Mar. 31, 2024   497,000      
Beginning balance at Mar. 31, 2024 13,490 $ 5 20 13,621 (156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 566     566  
Other comprehensive income (loss)         6
Other comprehensive income (loss) 6        
Common stock issued, stock-based compensation plans (in shares)   1,000      
Common stock issued, stock-based compensation plans 15   15    
Stock-based compensation expense 48   48    
Repurchases of common stock (in shares)   (1,000)      
Repurchases of common stock (76)   (68) (8)  
Dividends declared (151)     (151)  
Ending balance (in shares) at Jun. 30, 2024   497,000      
Ending balance at Jun. 30, 2024 13,898 $ 5 15 14,028 (150)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 582     582  
Other comprehensive income (loss) 192       192
Other comprehensive income (loss) 192        
Common stock issued, stock-based compensation plans (in shares)   1,000      
Common stock issued, stock-based compensation plans 14   14    
Common stock issued, acquisition related (in shares)   1,000      
Common stock issued, acquisition related 113   113    
Stock-based compensation expense 44   44    
Repurchases of common stock (in shares)   (3,000)      
Repurchases of common stock (242)   (128) (114)  
Dividends declared (149)     (149)  
Ending balance (in shares) at Sep. 30, 2024   496,000      
Ending balance at Sep. 30, 2024 $ 14,452 $ 5 58 14,347 42
Beginning balance (in shares) at Dec. 31, 2024 495,000 495,000      
Beginning balance at Dec. 31, 2024 $ 14,408 $ 5 13 14,686 (296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 663     663  
Other comprehensive income (loss)         131
Other comprehensive income (loss) 131        
Common stock issued, stock-based compensation plans (in shares)   1,000      
Common stock issued, stock-based compensation plans 19   19    
Stock-based compensation expense 42   42    
Repurchases of common stock (in shares)   (3,000)      
Repurchases of common stock (210)   (55) (155)  
Dividends declared (154)     (154)  
Ending balance (in shares) at Mar. 31, 2025   493,000      
Ending balance at Mar. 31, 2025 $ 14,899 $ 5 19 15,040 (165)
Beginning balance (in shares) at Dec. 31, 2024 495,000 495,000      
Beginning balance at Dec. 31, 2024 $ 14,408 $ 5 13 14,686 (296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,582        
Other comprehensive income (loss) $ 232       232
Ending balance (in shares) at Sep. 30, 2025 483,000 483,000      
Ending balance at Sep. 30, 2025 $ 14,897 $ 5 14 14,942 (64)
Beginning balance (in shares) at Mar. 31, 2025   493,000      
Beginning balance at Mar. 31, 2025 14,899 $ 5 19 15,040 (165)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 645        
Other comprehensive income (loss)         208
Other comprehensive income (loss) 208        
Common stock issued, stock-based compensation plans 14   14    
Stock-based compensation expense 48   48    
Repurchases of common stock (in shares)   (4,000)      
Repurchases of common stock (372)   (67) (305)  
Dividends declared (154)     (154)  
Ending balance (in shares) at Jun. 30, 2025   489,000      
Ending balance at Jun. 30, 2025 15,288 $ 5 14 15,226 43
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 274        
Other comprehensive income (loss) (107)       (107)
Other comprehensive income (loss) (107)        
Common stock issued, stock-based compensation plans (in shares)   1,000      
Common stock issued, stock-based compensation plans 13   13    
Stock-based compensation expense 47   47    
Repurchases of common stock (in shares)   (7,000)      
Repurchases of common stock (466)   (60) (406)  
Dividends declared $ (152)     (152)  
Ending balance (in shares) at Sep. 30, 2025 483,000 483,000      
Ending balance at Sep. 30, 2025 $ 14,897 $ 5 $ 14 $ 14,942 $ (64)